HEPCLUDEX
NDC 61958-3104, BULEVIRTIDE, injection, powder, lyophilized, for solution, from Gilead Sciences, Inc..
- Product NDC
- 61958-3104
- Status
- Listed
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761468
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BULEVIRTIDE ACETATE8.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61958-3104-1 | 61958310401 | 30 VIAL, SINGLE-DOSE in 1 CARTON (61958-3104-1) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (61958-3104-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/12391cc2-38c2-4cf5-86d3-2be9370127fc
Use it
Look up 61958-3104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61958-3104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.